(S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]-indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
CAS: 86639-62-5
Ref. 3D-LDA63962
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire | ||
250mg | To inquire |
Product Information
- 9-Nitrocamptothecin (Rubitecan)
4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]-indolizino[1,2-b]quinoline (EHNQ) is a potent antitumor agent that inhibits the growth of solid tumours by inducing apoptosis. EHNQ induces apoptosis through a caspase dependent pathway and triggers DNA damage. This drug has been shown to have potent anti-tumor activity in both bone cancer and subcutaneous tumors in mice. This compound also showed an increased antitumor response when used in combination with other chemotherapy drugs such as mitomycin C and vincristine sulfate. EHNQ has been shown to cause histological changes in the liver of animals treated with higher doses, but no such effects were observed at lower doses.
Chemical properties
Technical inquiry about: 3D-LDA63962 (S)-4-Ethyl-4-hydroxy-10-nitro-1H-pyrano[3',4':6,7]-indolizino[1,2-b]quinoline-3,14(4H,12H)-dione
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.